A panel of experts discuss evidence generation planning to optimize clinical and commercial success and improve patient outcomes.
Innovative new treatments with the potential to improve patients' lives face unprecedented obstacles, including greater complexity and cost, more stringent evidence requirements to secure patient access beyond regulatory approval, a greater diversity of stakeholders and decision-makers, and competition for share of voice.
Thus, stakeholder engagement - whether with HCPs, patients, regulators, advocates, or payers - has become increasingly science-based and evidence-driven. Generating actionable evidence, including RWE and HEOR data, in a timely manner has become a key objective. Further, the ability to anticipate, shape and optimize product development has become one of the most critical success factors for realizing an innovation's full promise.
Through illustrative case studies and expert panel discussion, this session uncovers how integrated evidence generation planning - beginning early in the product development lifecycle - can optimize an asset's value story, and lead to greater clinical and commercial success and improved patient outcomes.
Presenters
Colin Oliver
Colin Oliver is a managing director in the medical affairs consulting practice at Syneos Health with over 10 years of pharmaceutical/biotechnology experience at small, medium and large companies. Colin has worked in the field as a Medical Science Liaison to building and leading a global medical affairs organization.
Anila Dede
Anila Dede is an industry thought leader with 20 years of experience & strong business acumen focused on business trends, RWE challenges, & opportunities. She is an expert in addressing study implementation challenges in real world setting with a track record in developing compound strategy, study design, program & portfolio management.
Erwin De Cock
Erwin is an accomplished real-world research scientist with over 20 years of consultancy experience. He has specialized in the conceptualization and design of a wide variety of real world and late phase studies. Within Syneos Health, Erwin combines a scientific role with key business responsibilities including the development of innovative solutions and growth of real-world services.
Arshi Gupta
Arshi Gupta has 12+ years of experience in the healthcare and life sciences industry. She is at the helm of global and regional efforts leading to transform Clinical, Medical Affairs, and Commercial activities, with the last few years focused on evolution of Medical Affairs.
Sponsor
Syneos Health
Content Partners
HealthEconomics.com
HealthEconomics.com is the world’s largest Connected Community™ for Value, Evidence and Access in the life sciences industry.
HealthEconomics.com provides a single global link to the health economic and outcomes research (HEOR), real-world evidence (RWE), and Market Access (MA) stakeholder communities. Since 1993, we have provided unparalleled access to drive business, improve knowledge, and connect researchers and payer decision-makers world-wide.
Our 27,000 engaged readers rely on HealthEconomics.com as the most reliable, credible and curated digital hub for the latest news, insights, educational opportunities, and industry benchmarks in HEOR, RWE and MA. Our advertisers, numbering more than 500 with a 91% retention rate, depend upon HealthEconomics.com for best-in-class global brand awareness and business development solutions. Our aim is to connect people with expert-driven content and resources — all in one place — with the corporate mission to advance communication about healthcare value.
